Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.Ibalizumab has anti-HIV-1 infectious activity and may be used to maintain normal immu
CAS Number:
[680188-33-4]
Target:
HIV Protease
* VAT and and shipping costs not included. Errors and price changes excepted